People Finder
- Find a person by name or search via surname initial
  
  Quick search
  - A
  - B
  - C
  - D
  - E
  - F
  - G
  - H
  - I
  - J
  - K
  - L
  - M
  - N
  - O
  - P
  - Q
  - R
  - S
  - T
  - U
  - V
  - W
  - X
  - Y
  - Z

Industries

Practices
- Go to Practices Section

Knowledge Library

Global Directory

Join Us

Events

Search Thought Leadership

To refine your search select a single option or a combination of options:

Find

reset

THOUGHT LEADERSHIP

Displaying Thought Leadership item(s) about Healthcare & Life Sciences

9 results

- September 30, 2020
  
  Securities Litigation Trends During Covid-19
  
  In an article for Bloomberg Law, partners Blair Connelly and Colleen Smith and associate Cindy Guan, explore patterns emerging in securities litigation in the age of the pandemic.
  
  share view
- September 25, 2020
  
  UK Issues New Guidance for Medical Device Regulation After Brexit
  
  The MHRA offers new guidance on how medical devices will be regulated in the UK from 1 January 2021.
  
  share view
- September 21, 2020
  
  Healthcare AI Deals a Tonic for PE Investors
  
  Healthcare artificial intelligence is a promising sector for PE investors that requires careful navigation, particularly given divergent regulatory approaches.
  
  share view
- May 28, 2020
  
  Rise in Securities Class Action Filings in Life Sciences Sector
  
  Last year proved to be another record period for securities class actions, with a 13% increase in cases filed compared with 2018, and a 24% increase in claims brought against life sciences companies compared with 2018, write partners Michele Johnson and Colleen Smith in In Vivo.
  
  share view
- April 08, 2020
  
  COVID-19: DHSC and MHRA Pave the Way for Increased Ventilator Production
  
  UK companies interested in producing ventilators and other critical equipment may benefit from regulatory exemptions and use government product specifications.
  
  share view
- April 07, 2020
  
  New EU Medical Devices Regulation to Be Postponed Until 2021
  
  European Commission proposes one-year postponement in light of the COVID-19 crisis.
  
  share view
- April 02, 2020
  
  CMS Expands Healthcare Delivery Options During COVID-19 Pandemic
  
  CMS takes unprecedented action to streamline regulatory requirements, expand the availability and reach of healthcare resources, and encourage new delivery models.
  
  share view
- March 31, 2020
  
  Expanded Medicare Payment Policy and CARES Act Provide Financial Relief for Healthcare Providers and Suppliers
  
  Accelerated and advance payments, as well as higher reimbursement rates, aim to bridge the gap for US healthcare providers during COVID-19 crisis.
  
  share view
- February 24, 2020
  
  UK MRC Clarifies When Health Data Is Anonymised in Research Context
  
  Research participants must identify which data sets constitute personal data to ensure compliance with the GDPR.
  
  share view

The cookies we use

Latham & Watkins uses cookies which are essential for the operation of our website. We would also like to use analytics cookies to help us understand how visitors use our site so we can continue to improve it, but we will only do so with your consent. We use a cookie to remember your preferences. You can access and change your preferences at any time by clicking on the gear icon.

Essential cookies

Essential cookies enable the core functionality of our website such as security, authentication, and accessibility. You can change your browser settings to disable these cookies, but it may affect your ability to access and use the site.

Analytics cookies

We would like to use Google Analytics to analyse how visitors interact with our site so that we can continue to develop and improve it. These services are provided in Europe by Google Ireland Limited and elsewhere by Google LLC and affiliated Google Entities. Google Analytics uses cookies to collect information about visitors to our site (data related to the device/browser, IP address and on-site activity). They measure and report on user interactions, such as the volume and nature of visits to our site. If you agree to the use of these analytics cookies, please move the slider to “On.” Please refer to the Cookies Policy on our Privacy page for more information.

Latham & Watkins LLP has office locations in Beijing, Boston, Brussels, Century City, Chicago, Dubai, Düsseldorf, Frankfurt, Hamburg, Hong Kong, Houston, London, Los Angeles, Madrid, Milan, Moscow, Munich, New York, Orange County, Paris, Riyadh,* San Diego, San Francisco, Shanghai, Seoul, Silicon Valley, Singapore, Tokyo, and Washington, D.C.
*In cooperation with the Law Office of Salman M. Al-Sudairi